Rotavirus capsid protein VP5* permeabilizes membranes

Proteolytic cleavage of the VP4 outer capsid spike protein into VP8* and VP5* proteins is required for rotavirus infectivity and for rotavirus-induced membrane permeability. In this study we addressed the function of the VP5* cleavage fragment in permeabilizing membranes. Expressed VP5* and truncated VP5* proteins were purified by nickel affinity chromatography and assayed for their ability to permeabilize large unilamellar vesicles (LUVs) preloaded with carboxyfluorescein (CF). VP5* and VP5* truncations, but not VP4 or VP8*, permeabilized LUVs as measured by fluorescence dequenching of released CF. Similar to virus-induced CF release, VP5*-induced CF release was concentration and temperature dependent, with a pH optimum of 7.35 at 37 degrees C, but independent of the presence of divalent cations or cholesterol. VP5*-induced permeability was completely inhibited by VP5*-specific neutralizing monoclonal antibodies (2G4, M2, or M7) which recognize conformational epitopes on VP5* but was not inhibited by VP8*-specific neutralizing antibodies. In addition, N-terminal and C-terminal VP5* truncations including residues 265 to 474 are capable of permeabilizing LUVs. These findings demonstrate that VP5* permeabilizes membranes in the absence of other rotavirus proteins and that membrane-permeabilizing VP5* truncations contain the putative fusion region within predicted virion surface domains. The ability of recombinant expressed VP5* to permeabilize membranes should permit us to functionally define requirements for VP5*-membrane interactions. These findings indicate that VP5* is a specific membrane-permeabilizing capsid protein which is likely to play a role in the cellular entry of rotaviruses.     

Effect of Mutations in VP5* Hydrophobic Loops on Rotavirus Cell Entry

Experiments in cell-free systems have demonstrated that the VP5* cleavage fragment of the rotavirus spike protein, VP4, undergoes a foldback rearrangement that translocates three clustered hydrophobic loops from one end of the molecule to the other. This conformational change resembles the foldback rearrangements of enveloped virus fusion proteins. By recoating rotavirus subviral particles with recombinant VP4 and VP7, we tested the effects on cell entry of substituting hydrophilic for hydrophobic residues in the clustered VP5* loops. Several of these mutations decreased the infectivity of recoated particles without preventing either recoating or folding back. In particular, the V391D mutant had a diminished capacity to interact with liposomes when triggered to fold back by serial protease digestion in solution, and particles recoated with this mutant VP4 were 10,000-fold less infectious than particles recoated with wild-type VP4. Particles with V391D mutant VP4 attached normally to cells and internalized efficiently, but they failed in the permeabilization step that allows coentry of the toxin α-sarcin. These findings indicate that the hydrophobicity of the VP5* apex is required for membrane disruption during rotavirus cell entry.Cell entry by nonenveloped viruses requires disruption or perforation of a membrane and translocation of a modified virion or an infectious genome into the cytosol (30). A variety of mechanisms have evolved to carry out these steps. Viruses with double-stranded RNA (dsRNA) genomes, such as rotaviruses and orthoreoviruses, deliver an inner capsid particle to the cytosol of the target cell. The rotavirus inner capsid particle, known as a “double-layered particle” (DLP) because of its two-shell structure (Fig. ​(Fig.1),1), contains the 11 viral genome segments and the enzymes required for RNA synthesis and capping (13). The DLP remains intact throughout the infection, and new plus-sense RNA strands are made, capped, and extruded from the particle (17, 23). The outer layer of the virion (“triple-layered particle” [TLP]) contains two protein species, VP4 and VP7, which provide the molecular apparatus for cell attachment and membrane penetration.Open in a separate windowFIG. 1.Structures and model for conformational rearrangements of VP4. (Top center) Surface rendering from electron cryomicroscopy of a three-dimensional reconstruction of the rotavirus particle. A trypsin-cleaved VP4 spike (red) is boxed. The cutaway shows the multiple layers of the TLP. The VP7 layer is in yellow. The layers of the DLP are in green (VP6) and blue (VP2). (Top right) The VP4 primary structure indicating the boundaries of proteolytic products. (Bottom) Model for VP4 conformational rearrangements accompanying membrane penetration. (Step 1) Trypsin-activated VP4, in a schematic representation of a spike in roughly the orientation of the boxed spike in the rendering of a virion. The VP4 trimer has a 3-fold-symmetric “foot” but an asymmetrically organized projection. The ribbon diagram shows a dimeric form of the VP5 β-barrel domain (or antigen domain), which fits the dimer-clustered “body” of the projection, and the inset shows details of the three conserved hydrophobic loops that cap the β-barrel domain of VP5*. The hydrophobic residues mutated in this study are labeled. (Step 2) Dissociation of VP8* exposes the hydrophobic loops (shown as purple ovals) of VP5*. VP5* extends and engages a target membrane with the hydrophobic loops, probably from all three subunits. (Step 3) VP5* folds back to a stable trimeric structure, represented by the VP5CT crystal structure. This foldback is proposed to drive membrane penetration.VP4 makes up the “spikes,” which are evident on mature rotavirus particles only after tryptic cleavage of VP4 into fragments VP8* and VP5* (Fig. ​(Fig.1).1). This cleavage activates virions for efficient infectivity (12). Prior to cleavage, the outer parts of VP4 are probably flexibly linked to the “foot” (10), which is clamped by VP7 onto the underlying DLP. Each spike contains three copies of VP4. The virion-distal part of the spike appears to be dimer clustered and displaced from the local axis; electron cryomicroscopy has shown the foot to be a 3-fold-symmetric trimer (18). This unusual mismatch of symmetries suggests that the spike structure may be metastable and that a suitable trigger may induce it to rearrange further.Structural analyses of various VP4 domains, of VP7, and of DLPs and TLPs (2, 6, 10, 11, 18, 31, 33), together with biochemical studies of VP7, VP4, and VP4 fragments (8, 9, 28, 29, 32), suggest the model illustrated in Fig. ​Fig.1.1. Trypsin-cleaved VP4 forms the spike, in which the “body” regions of two of the three VP5* fragments cluster together; the two associated VP8* fragments cover the hydrophobic tips of these clustered VP5* β-barrel domains (designated in previous papers “antigen domains” [VP5Ag]). All three subunits contribute to the C-terminal foot. VP7, a calcium-stabilized trimer, locks the VP4 foot in place. Dissociation of VP7 (“uncoating”), induced by a lowered calcium concentration, allows VP5* to rearrange further into a symmetrical trimer, with the VP5* antigen domains rotated by roughly 180°, so that their hydrophobic tips point toward the foot. This step probably requires loss of VP8* and formation of a transient extended intermediate.The properties of recombinant VP4 in solution correlate with the steps of the model described above. Full-length recombinant VP4 is predominantly monomeric in solution (8). Successive cleavages with chymotrypsin and trypsin produce “VP5CT,” a fragment that coincides with VP5* at its N terminus but has lost residues corresponding roughly to the foot at its C terminus (Fig. ​(Fig.1)1) (8). It is an SDS-resistant trimer that remains associated unless it is heated to 95°C in SDS-PAGE sample buffer (8, 32). Authentic VP5* released from uncoated virions also forms an SDS-resistant trimer (32).Studies of the properties of VP4 fragments, prepared by proteolysis of monomeric VP4 or by release from virions, provide evidence for a transient, extended intermediate of VP5* (Fig. ​(Fig.1)1) and for its interaction with synthetic membranes (29). Digestion of recombinant VP4 with chymotrypsin and trypsin in the presence of liposomes leads to membrane association of the resulting VP5CT, but preformed VP5CT does not associate with liposomes added after cleavage and trimerization are complete. Authentic VP5* has similar properties: if released from virions (by chelating Ca²⁺) in the presence of liposomes, it associates with them, but it does not do so if the liposomes are added after uncoating. In both cases, the lipid bilayer appears to have captured a transient intermediate in the rearrangement to the folded back, trimeric species revealed by the VP5CT crystal structure.Three loops (designated BC, DE, and FG) form the hydrophobic patch that caps one end of the VP5* β-barrel domain (Fig. ​(Fig.1)1) (10, 31). The position of this patch makes it a likely candidate to mediate the membrane interactions described above; indeed, the FG loop amino acid sequence resembles that of an alphavirus fusion loop, suggesting that it could insert directly into a lipid bilayer. We report here experiments that test whether the hydrophobicity of the VP5* loops is important for rotavirus infectivity and for membrane association of the trimeric VP5* intermediate. Because sequential addition of recombinant VP4 and VP7 to rotavirus DLPs yields recoated particles (RPs) that are fully infectious after trypsin priming (28), we can incorporate VP4 with mutated hydrophobic residues to examine the progress of such particles along the cell entry pathway. We show that a modification in a VP4 hydrophobic loop reduces infectivity by blocking a membrane permeabilization step that follows cell attachment and endocytic internalization. The results support the proposal that these loops couple a conformational change in VP5* to disruption or perforation of an endosomal membrane.     

Location of intrachain disulfide bonds in the VP5* and VP8* trypsin cleavage fragments of the rhesus rotavirus spike protein VP4.

Because the rotavirus spike protein VP4 contains conserved Cys residues at positions 216, 318, 380, and 774 and, for many animal rotaviruses, also at position 203, we sought to determine whether disulfide bonds were structural elements of VP4. Electrophoretic analysis of untreated and trypsin-treated rhesus rotavirus (RRV) and simain rotavirus SA11 in the presence and absence of the reducing agent dithioerythritol revealed that VP4 and its cleavage fragments VP5* and VP8* possessed intrachain disulfide bonds. Given that the VP8* fragments of RRV and SA11 contain only two Cys residues, those at positions 203 and 216, these data indicated that these two residues were covalently linked. Electrophoretic examination of truncated species of VP4 and VP4 containing Cys-->Ser mutations synthesized in reticulocyte lysates provided additional evidence that Cys-203 and Cys-216 in VP8* of RRV were linked by a disulfide bridge. VP5* expressed in vitro was able to form a disulfide bond analogous to that in the VP5* fragment of trypsin-treated RRV. Analysis of a Cys-774-->Ser mutant of VP5* showed that, while it was able to form a disulfide bond, a Cys-318-->Ser mutant of VP5* was not. These results indicated that the VP4 component of all rotaviruses, except B223, contains a disulfide bond that links Cys-318 and Cys-380 in the VP5* region of the protein. This bond is located between the trypsin cleavage site and the putative fusion domain of VP4. Because human rotaviruses lack Cys-203 and, hence, unlike many animal rotaviruses cannot possess a disulfide bond in VP8*, it is apparent that VP4 is structurally variable in nature, with human rotaviruses generally containing one disulfide linkage and animal rotaviruses generally containing two such linkages. Considered with the results of anti-VP4 antibody mapping studies, the data suggest that the disulfide bond in VP5* exists within the 2G4 epitope and may be located at the distal end of the VP4 spike on rotavirus particles.     

Rotavirus VP4 and VP7-Derived Synthetic Peptides as Potential Substrates of Protein Disulfide Isomerase Lead to Inhibition of Rotavirus Infection

Rotavirus infection of MA104 cells has been shown to be inhibited by cell membrane-impermeant thiol/disulfide exchange inhibitors and anti-PDI antibodies. To characterise the amino acid sequences of rotavirus structural proteins potentially mediating cell surface PDI?Csubstrate interactions, rotavirus-derived peptides from VP4 and VP7 (RRV) and VP7 (Wa), and their modified versions containing serine instead of cysteine were synthesized. Cysteine-containing VP7 peptides corresponding to residues 189?C210 or 243?C263 caused an infectivity inhibitory effect of about 64 and 85?%, respectively, when added to cells. Changing cysteine to serine significantly decreased the inhibitory effect. A cysteine-containing peptide corresponding to VP4 residues 200?C219 and its scrambled version reduced infectivity by 92 and 80?%, respectively. A cysteine to serine change in the original VP4 200?C219 peptide did not affect its inhibitory effect. Non-rotavirus related sequences containing cysteine residues efficiently inhibited rotavirus infectivity. Antibodies against VP7 residues 189?C210 or 243?C263 significantly inhibited rotavirus infectivity only after virus attachment to cells had occurred, whereas those against VP4 200?C219 peptide inhibited infectivity irrespective of whether virus or cell-attached virus was antibody-treated. A direct PDI?Cpeptide interaction was shown by ELISA for cysteine-containing VP7 and VP4 peptides. Virus?Ccell attachment was unaffected by the peptides inhibiting virus infectivity. The results showed that even though cysteine residues in the peptides tested are important in both virus infectivity inhibition and in vitro PDI?Cpeptide interaction, the accompanying amino acid sequence also plays some role. As a whole, our findings further support our hypothesis that cell surface PDI from MA104 cells might be contributing to rotavirus entry at a post-attachment step.     

Rotavirus proteins VP7, NS28, and VP4 form oligomeric structures.

Sucrose gradient sedimentation analysis of rotavirus SA11-infected Ma104 cells revealed the presence of oligomers of VP7, the structural glycoprotein, and NS28, the nonstructural glycoprotein. Cross-linking the proteins, either before or after sucrose gradient centrifugation, stabilizes oligomers, which can be analyzed by nonreducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) after immunoprecipitation. The major NS28 oligomer was tetrameric, though dimers and higher-order structures were observed as well. VP7 formed predominantly dimers, and again tetramers and higher oligomeric forms were present. Each oligomer of VP7 and NS28 sedimented at the same characteristic rate through the sucrose gradient either in the presence or absence of cross-linking. Monomers could not be cross-linked to form oligomers, demonstrating that cross-linked oligomers were not artifactually derived from monomers. Reversing the cross-linking of immunoprecipitated VP7 on reducing SDS-PAGE resulted in the appearance of only the monomeric form of VP7. Dissociation of the NS28 oligomers resulted in stable dimers as well an monomers. In the faster-sedimenting fractions, a 16S to 20S complex, which contained the rotavirus outer shell proteins VP7 and VP4 cross-linked to NS28, was observed. These complexes were shown not to be associated with any known subviral particle. The association of VP4, NS28, and VP7 may represent sites on the endoplasmic reticulum membrane that participate in the budding of the single-shelled particles into the lumen of the endoplasmic reticulum, where maturation to double-shelled particles occurs.     

重叠PCR法合成轮状病毒抗原基因VP4

用重叠延伸PCR(overlap extension PCR)法获得轮状病毒VP4基因.根据Genbank中鼠VP4基因的序列设计34对引物,用overlap PCR法合成VP4全基因的两个片段A、B,将A、B分别连入pMD19-T simple载体,测序结果显示,成功合成了VP4全基因.证明了重叠延伸PCR法是获得目的基因的有效方法.     

Rotavirus nonstructural protein NSP5 interacts with major core protein VP2

Rotavirus is a nonenveloped virus with a three-layered capsid. The inner layer, made of VP2, encloses the genomic RNA and two minor proteins, VP1 and VP3, with which it forms the viral core. Core assembly is coupled with RNA viral replication and takes place in definite cellular structures termed viroplasms. Replication and encapsidation mechanisms are still not fully understood, and little information is available about the intermolecular interactions that may exist among the viroplasmic proteins. NSP2 and NSP5 are two nonstructural viroplasmic proteins that have been shown to interact with each other. They have also been found to be associated with precore replication intermediates that are precursors of the viral core. In this study, we show that NSP5 interacts with VP2 in infected cells. This interaction was demonstrated with recombinant proteins expressed from baculovirus recombinants or in bacterial systems. NSP5-VP2 interaction also affects the stability of VP6 bound to VP2 assemblies. The data presented showed evidence, for the first time, of an interaction between VP2 and a nonstructural rotavirus protein. Published data and the interaction demonstrated here suggest a possible role for NSP5 as an adapter between NSP2 and the replication complex VP2-VP1-VP3 in core assembly and RNA encapsidation, modulating the role of NSP2 as a molecular motor involved in the packaging of viral mRNA.     

Rotavirus VP8*: Phylogeny, Host Range, and Interaction with Histo-Blood Group Antigens

The distal portion of rotavirus (RV) VP4 spike protein (VP8*) is implicated in binding to cellular receptors, thereby facilitating viral attachment and entry. While VP8* of some animal RVs engage sialic acid, human RVs often attach to and enter cells in a sialic acid-independent manner. A recent study demonstrated that the major human RVs (P[4], P[6], and P[8]) recognize human histo-blood group antigens (HBGAs). In this study, we performed a phylogenetic analysis of RVs and showed further variations of RV interaction with HBGAs. On the basis of the VP8* sequences, RVs are grouped into five P genogroups (P[I] to P[V]), of which P[I], P[IV], and P[V] mainly infect animals, P[II] infects humans, and P[III] infects both animals and humans. The sialic acid-dependent RVs (P[1], P[2], P[3], and P[7]) form a subcluster within P[I], while all three major P genotypes of human RVs (P[4], P[6], and P[8]) are clustered in P[II]. We then characterized three human RVs (P[9], P[14], and P[25]) in P[III] and observed a new pattern of binding to the type A antigen which is distinct from that of the P[II] RVs. The binding was demonstrated by hemagglutination and saliva binding assay using recombinant VP8* and native RVs. Homology modeling and mutagenesis study showed that the locations of the carbohydrate binding interfaces are shared with the sialic acid-dependent RVs, although different amino acids are involved. The P[III] VP8* proteins also bind the A antigens of the porcine and bovine mucins, suggesting the A antigen as a possible factor for cross-species transmission of RVs. Our study suggests that HBGAs play an important role in RV infection and evolution.     

Antibody-Independent Protection against Rotavirus Infection of Mice Stimulated by Intranasal Immunization with Chimeric VP4 or VP6 Protein

This study was to determine whether individual rotavirus capsid proteins could stimulate protection against rotavirus shedding in an adult mouse model. BALB/c mice were intranasally or intramuscularly administered purified Escherichia coli-expressed murine rotavirus strain EDIM VP4, VP6, or truncated VP7 (TrVP7) protein fused to the 42.7-kDa maltose-binding protein (MBP). One month after the last immunization, mice were challenged with EDIM and shedding of rotavirus antigen was measured. When three 9-microg doses of one of the three rotavirus proteins fused to MBP were administered intramuscularly with the saponin adjuvant QS-21, serum rotavirus immunoglobulin G (IgG) was induced by each protein. Following EDIM challenge, shedding was significantly (P = 0.02) reduced (i.e., 38%) in MBP::VP6-immunized mice only. Three 9-micrograms doses of chimeric MBP::VP6 or MBP::TrVP7 administered intranasally with attenuated E. coli heat-labile toxin LT(R192G) also induced serum rotavirus IgG, but MBP::VP4 immunization stimulated no detectable rotavirus antibody. No protection against EDIM shedding was observed in the MBP::TrVP7-immunized mice. However, shedding was reduced 93 to 100% following MBP::VP6 inoculation and 56% following MBP::VP4 immunization relative to that of controls (P = <0.001). Substitution of cholera toxin for LT(R192G) as the adjuvant, reduction of the number of doses to 1, and challenge of the mice 3 months after the last immunization did not reduce the level of protection stimulated by intranasal administration of MBP::VP6. When MBP::VP6 was administered intranasally to B-cell-deficient microMt mice that made no rotavirus antibody, shedding was still reduced to <1% of that of controls. These results show that mice can be protected against rotavirus shedding by intranasal administration of individual rotavirus proteins and that this protection can occur independently of rotavirus antibody.     

Recombinant VP4 of human rhinovirus induces permeability in model membranes

In common with all nonenveloped viruses, the mechanism of picornavirus membrane penetration during cell entry is poorly understood. The small, myristylated capsid protein VP4 has been implicated in this process. Here we show that recombinant VP4 of human rhinovirus 16 has the ability to associate with and induce membrane permeability in otherwise intact liposomes. This provides further evidence that VP4 plays a key role in picornavirus cell entry.     

轮状病毒VP7基因的克隆与表达

应用聚合酶链式反应技术(PCR)扩增轮状病毒VP7基因,并将其克隆到pMD18-T simple载体上,对重组子进行PCR检测和限制性内切酶分析,并测定DNA全序列。结果显示,克隆片段全长为981 bp。将轮状病毒VP7基因定向的克隆到原核表达载体pET-32a启动子下游,构建原核表达载体pET-32aVP7。将质粒pET-32aVP7转化Transetta表达菌株进行诱导表达,裂解菌体细胞抽提蛋白质进行SDS-PAGE。结果表明,轮状病毒壳蛋白VP7基因在Transetta表达菌株内得到成功表达。     

免疫荧光法检测原核和真核细胞中表达的轮状病毒外壳蛋白VP4

目的：用免疫荧光法快速检测原核和真核细胞中表达的轮状病毒（RV）外壳蛋白VP4。方法：以抗VP4的抗体为一抗、FITC标记的羊抗豚鼠IgG为二抗,用免疫荧光方法检测在大肠杆菌BL21（DE3）中重组表达的同源RVVP4;检测SA11或Wa株RV感染MA104细胞后不同时间段病毒VP4的合成及其在感染细胞中的分布情况。结果：用免疫荧光法可直接检测到原核细胞中表达的外源蛋白,也可检测到病毒蛋白在真核细胞中的分布情况。结论：免疫荧光法可特异、方便、快速地检测RV VP4在原核和真核细胞中的表达;来源于RV TB—Chen株的VP4抗体可特异性识别同源病毒VP4,交叉识别SA11或Wa株的VP4。     

Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice

Background  

Porcine rotavirus infection is a significant cause of morbidity and mortality in the swine industry necessitating the development of effective vaccines for the prevention of infection. Immune responses associated with protection are primarily mucosal in nature and induction of mucosal immunity is important for preventing porcine rotavirus infection.     

被动免疫轮状病毒NSP4&VP7双抗原重组腺病毒对感染乳鼠的排毒保护作用

为建立小鼠轮状病毒(Rotavirus,RV)感染动物模型,研究可同时表达轮状病毒NSP4 (Nonstructural protein 4)和VP7(Viral protein 7)的重组腺病毒疫苗免疫孕鼠后对新生乳鼠感染RV的被动保护作用.新生乳鼠口服异源株轮状病毒Wa、ZTR-68或SA11株后(分2次给予,每次含5×104 CCID50的RV),观察乳鼠是否有腹泻症状、肠道病理变化,检测乳鼠粪便排毒百分率;另以重组腺病毒rAd-NSP4-VP7免疫孕鼠后,检测母鼠血清抗体产生情况,并对比乳鼠粪便中RV抗原检出率初步评价疫苗的被动免疫保护作用.发现口服异源株RV的乳鼠未出现类似人类婴幼儿感染后的明显腹泻症状,但在粪便中可检测到RV抗原的存在(Wa、ZTR-68攻毒组均超过80％).经rAd-NSP4-VP7被动免疫的乳鼠接受Wa和ZTR-68攻毒后其粪便中的RV检出率比未受到被动免疫保护的对照组降低(P＜0.05).rAd-NSP4-VP7重组腺病毒免疫母鼠可显示出对孕鼠感染RV的被动免疫保护作用.     

SA11株轮状病毒VP7基因的克隆及表达

采用RT PCR方法 ,从提取的SA1 1株轮状病毒总RNA中扩增出VP7基因片段 ,进行鉴定后 ,将该片段克隆于真核表达载体pEF1 HisC dhfr,构建成重组质粒pEF1 HisC dhfr VP7,然后用质脂体法转染COS 7细胞 ,进行真核系统的表达 .获得了长 981bp的PCR片段 ,序列分析结果与已知VP7序列相同 .表达后经细胞超声破碎 ,Westernblot检测表达产物 ,在相对分子质量 38× 1 0 3 处有表达条带 ,表达蛋白主要存在于上清中 .因此 ,获得了VP7基因 ,并在COS 7细胞中获得了表达 ,表达蛋白质免疫Balb c小鼠 ,获得了具有特异性结合活性的抗体     

表达轮状病毒G2和G3型vp7基因重组腺病毒的免疫效果

为探索以非复制型腺病毒为表达载体的多价轮状病毒(Rotavirus,RV)基因工程疫苗的可行性,在前期工作的基础上,对表达我国G2和G3型RV流行毒株vp7基因的重组腺病毒的免疫效果进行了研究。分别用表达G2和G3型vp7基因的重组腺病毒rvAdG2VP7、rvAdG3VP7经滴鼻和灌胃两种途径免疫Balb/c小鼠,对免疫后小鼠的血清抗体、黏膜抗体和相关的细胞因子水平进行了检测和比较。结果表明,用表达G2和G3型vp7基因的重组腺病毒经滴鼻和灌胃两种途径免疫小鼠后,均可诱导机体产生较强的RV特异性免疫反应,包括体液免疫、细胞免疫和黏膜免疫,并能产生中和抗体。但免疫反应以Th2类为主,Th1类反应也占有相当的比例。本研究为新型RV基因工程疫苗的深入研究奠定了基础。